| Autor: |
Wierzbicka M; Klinika Otolaryngologii i Onkologii Laryngologicznej, Uniwersytet Medyczny w Poznaniu., Fijuth J; Zakład Radioterapii, Uniwersytet Medyczny w Łodzi Zakład Teleradioterapii, Regionalny Ośrodek Onkologiczny, Szpital im. Mikołaja Kopernika w Łodzi., Składowski K; I Klinika Radioterapii i Onkologii Klinicznej, Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie w Gliwicach., Jurkiewicz D; Department of Otolaryngology, Military Institute of Medicine in Warsaw, Poland., Burduk P; Klinika Otolaryngologii, Onkologii Laryngologicznej i Chirurgii Szczękowo-Twarzowej, Collegium Medicum w Bydgoszczy., Miłoński J; Klinika Otolaryngologii, Onkologii Laryngologicznej, Audiologii i Foniatrii, II Katedry Otolaryngologii Uniwersytetu Medycznego w Łodzi., Niemczyk K; Chair and Clinic of Otorhinolaryngology, Head and Neck Surgery at the Medical University of Warsaw, Poland., Pietruszewska W; I Katedra Otolaryngologii, Klinika Otolaryngologii i Laryngologii Onkologicznej, Uniwersytet Medyczny w Łodzi., Rogowski M; Klinika Otolaryngologii, Uniwersytet Medyczny w Białymstoku., Stodulski D; Klinika Otolaryngologii, Wydział Lekarski, Gdański Uniwersytet Medyczny., Mikaszewski B; Klinika Otolaryngologii, Wydział Lekarski, Gdański Uniwersytet Medyczny. |
| Abstrakt: |
<b>Introduction:</b> Standard treatment for pleomorhic adenoma (PA) of the parotid gland is complete surgical excision. Radiotherapy (RT) as a primary treatment method is controversial and generally is not applied. However, RT might be considered as an adjuvant therapy in some selected cases. </br></br> <b>Aim:</b> The aim of this work was to define recommendations for RT in patients with parotid gland PA after primary surgical treatment.</br></br> <b>Material and methods:</b> Based on the results currently published in the literature and the authors' own experiences from leading Polish laryngological and oncological clinical centers dealing with the treatment of salivary gland tumors, the indications for irradia- tion and its methods in patients with PA of the salivary glands were discussed. </br></br> <b>Results and discussion:</b> Authors recommend personalized treatment based on multidisciplinary panel decisions in each patient. Adjuvant RT should be considered in cases of suboptimal resection of primary PA (close margin, intraoperative tumor spillage, risk of recurrence based on clinical factors and histological features), and in cases of PA recurrence. Doses/ fractions and techniques of irradiation are recommended depending on the clinical extension of the primary or recurrent tumor. </br></br> <b> Conclusions:</b> Adjuvant RT in PA treatment should be a result of a personalized multidisciplinary decision after considering all possible risks of irradiation consequences. Recommendations for this treatment should be taken into consideration. |
